B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LTR192G in H. pylori seronegative individuals

Vaccine

Volumn 21, Issue 5-6, 2003, Pages 562-565

  Losonsky, Genevieve A ^a,b,d   Kotloff, Karen L ^a,b   Walker, Richard I ^c  

^a Div of Infect Dis/Trop Pediat   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c Antex Biologics   (United States)

^d MEDIMMUNE   (United States)

Author keywords

B cell responses; Gastric antrum and duodenum; Helicobacter pylori

Indexed keywords

IMMUNOGLOBULIN A; LTR192G; TOXIN; VACCINE;

ARTICLE; B LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNIZATION; PRIORITY JOURNAL; STOMACH ANTRUM;

ADULT; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL TOXINS; BACTERIAL VACCINES; DUODENUM; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; HELICOBACTER PYLORI; HUMANS; HYDROLYSIS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PYLORIC ANTRUM; STOMACH; TRYPSIN; VACCINES, SYNTHETIC;

EID: 0037449490     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00259-1     Document Type: Article

References (13)

1. Lee C.K., Weltzin R., Thomas W.D., Kleanthous H., Ermak T.H., Soman G.et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:1999;161-172.
2. Losonsky G.A., Fantry G.T., Reymann M., Lim Y. Validation of a gastrointestinal explant system for measurement of mucosal antibody production. Clin. Diagn. Lab. Immunol. 6:1999;803-807.
3. Mattsson A., Lonroth H., Quiding-Jarbrink M., Svennerholm A.M. Induction of B cell responses in the stomach of Helicobacter pylori infected subjects after oral cholera vaccination. J. Clin. Invest. 102:1998;51-56.
4. Douce G, Dougan G, Pizza MG, Rappuoli R, Roberts M. Mutant pertussis and Escherichia coli heat-labile toxins as adjuvants for enhancing local and systemic immune responses to co-administered, non-living antigens. In: Levine MM, Woodrow CC, Kaper JB, Cobon GS, editors. New generation vaccines, 2nd ed. New York: Marcel Dekker, 1997. p. 253-62.
5. Elson C.O., Tomasi M., Chang T.T., Jobling M.G., Holmes R.K. Immunogenicity and adjuvanticity of mutant cholera toxin (CT) molecules. FASEB J. 9:1995;A290.
6. Lycke N., Holmgren J. The adjuvant effect of Vibrio cholerae and Eschericheria coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:1992;2277-2283.
7. Rollwagen F.M., Pacheco N.D., Clements J.D., Pavlovskis O., Rollins D.M., Walker R.I. Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant. Vaccine. 11:1993;1316-1320.
8. Freytag L.C., Clements J.D. Bacterial toxins as mucosal adjuvants. Curr. Top. Microbiol. Immunol. 236:1999;215-236.
9. Kotloff K.L., Sztein M.B., Wasserman S.S., Losonsky G.A., DiLorenzo S.C., Walker R.I. Clinical tolerance and immunogenicity of inactivated whole cell Helicobacter pylori vaccine with adjuvant among volunteers with and without sublinical gastric infection. Infect. Immun. 69:2001;3581-3590.
10. Tacket C.O., Mason H.S., Losonsky G.A., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:1998;607-609.
11. Michetti P., Kreiss C., Kotloff K.L., Porta N., Blanco J.L., Bachmann D.et al. Oral immunization with urease and E. coli heat-labile enterotoxin is safe and immunogenic in H. pylori infected adults. Gastroenterology. 116:1999;804-812.
12. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 11:1993;1179-1184.
13. Quiding M., Nordstrom I., Kilander A., Andersson G., Hanson L.A., Holmgren J.et al. Intestinal immune responses in humans: oral cholera vaccination induces strong intestinal antibody responses and interferon-γ production and invokes immunological memory. J. Clin. Invest. 88:1991;143-148.